Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 233

1.

Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility.

Stoyianni A, Goussia A, Pentheroudakis G, Siozopoulou V, Ioachim E, Krikelis D, Golfinopoulos V, Cervantes A, Bobos M, Fotsis T, Bellou S, Fountzilas G, Malamou-Mitsi V, Pavlidis N.

Anticancer Res. 2012 Apr;32(4):1273-81.

PMID:
22493359
2.

Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.

Ryu HS, Park DJ, Kim HH, Kim WH, Lee HS.

Hum Pathol. 2012 Apr;43(4):520-8. doi: 10.1016/j.humpath.2011.07.003. Epub 2011 Oct 21.

PMID:
22018628
3.

The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin.

Xiao S, Liu L, Lu X, Long J, Zhou X, Fang M.

J Cancer Res Clin Oncol. 2015 Aug;141(8):1465-74. doi: 10.1007/s00432-015-1937-y. Epub 2015 Feb 26.

PMID:
25716692
4.

Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.

Toll A, Masferrer E, Hernández-Ruiz ME, Ferrandiz-Pulido C, Yébenes M, Jaka A, Tuneu A, Jucglà A, Gimeno J, Baró T, Casado B, Gandarillas A, Costa I, Mojal S, Peña R, de Herreros AG, García-Patos V, Pujol RM, Hernández-Muñoz I.

J Dermatol Sci. 2013 Nov;72(2):93-102. doi: 10.1016/j.jdermsci.2013.07.001. Epub 2013 Jul 15.

PMID:
23928229
5.

Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.

Tsoukalas N, Aravantinou-Fatorou E, Tolia M, Giaginis C, Galanopoulos M, Kiakou M, Kostakis ID, Dana E, Vamvakaris I, Korogiannos A, Tsiambas E, Salemis N, Kyrgias G, Karameris A, Theocharis S.

Anticancer Res. 2017 Apr;37(4):1773-1778.

PMID:
28373440
6.

Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression.

Usami Y, Satake S, Nakayama F, Matsumoto M, Ohnuma K, Komori T, Semba S, Ito A, Yokozaki H.

J Pathol. 2008 Jul;215(3):330-9. doi: 10.1002/path.2365.

PMID:
18491351
7.

Prognostic significance of WNT and hedgehog pathway activation markers in cancer of unknown primary.

Fotopoulos G, Gousia A, Bareta E, Koumpis E, Chrisafi S, Bobos M, Malamou-Mitsi V, Fountzilas G, Pavlidis N, Pentheroudakis G.

Eur J Clin Invest. 2015 Nov;45(11):1145-52. doi: 10.1111/eci.12518. Epub 2015 Sep 13.

PMID:
26269154
8.

Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer.

Tanaka Y, Terai Y, Kawaguchi H, Fujiwara S, Yoo S, Tsunetoh S, Takai M, Kanemura M, Tanabe A, Ohmichi M.

Cancer Biol Ther. 2013 Jan;14(1):13-9. doi: 10.4161/cbt.22625. Epub 2012 Oct 31.

9.

Prognostic implications of epithelial to mesenchymal transition related proteins (E-cadherin, Snail) and hypoxia inducible factor 1α in endometrioid endometrial carcinoma.

Abouhashem NS, Ibrahim DA, Mohamed AM.

Ann Diagn Pathol. 2016 Jun;22:1-11. doi: 10.1016/j.anndiagpath.2016.01.004. Epub 2016 Feb 23.

PMID:
27180053
10.

Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients.

Verneuil L, Leboeuf C, Bousquet G, Brugiere C, Elbouchtaoui M, Plassa LF, Peraldi MN, Lebbé C, Ratajczak P, Janin A.

Oncotarget. 2015 Dec 8;6(39):41497-507. doi: 10.18632/oncotarget.6359.

11.

The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer.

Takai M, Terai Y, Kawaguchi H, Ashihara K, Fujiwara S, Tanaka T, Tsunetoh S, Tanaka Y, Sasaki H, Kanemura M, Tanabe A, Ohmichi M.

J Ovarian Res. 2014 Jul 27;7:76. doi: 10.1186/1757-2215-7-76.

12.

ILEI: a novel marker for epithelial-mesenchymal transition and poor prognosis in colorectal cancer.

Gao ZH, Lu C, Wang ZN, Song YX, Zhu JL, Gao P, Sun JX, Chen XW, Wang MX, Dong YL, Xu HM.

Histopathology. 2014 Oct;65(4):527-38. doi: 10.1111/his.12435. Epub 2014 Aug 6.

PMID:
24738665
13.

Epithelial-mesenchymal transition phenotype is associated with patient survival in small intestinal adenocarcinoma.

Kim A, Bae YK, Gu MJ, Kim JY, Jang KY, Bae HI, Lee HJ, Hong SM.

Pathology. 2013 Oct;45(6):567-73. doi: 10.1097/PAT.0b013e3283650bab.

PMID:
24018801
14.

Comprehensive multiple molecular profile of epithelial mesenchymal transition in intrahepatic cholangiocarcinoma patients.

Huang XY, Zhang C, Cai JB, Shi GM, Ke AW, Dong ZR, Zhang PF, Fan J, Peng BG, Zhou J.

PLoS One. 2014 May 9;9(5):e96860. doi: 10.1371/journal.pone.0096860. eCollection 2014.

15.

BPTF Associated with EMT Indicates Negative Prognosis in Patients with Hepatocellular Carcinoma.

Xiao S, Liu L, Fang M, Zhou X, Peng X, Long J, Lu X.

Dig Dis Sci. 2015 Apr;60(4):910-8. doi: 10.1007/s10620-014-3411-0. Epub 2014 Nov 2.

PMID:
25362514
16.

The role of biological markers of epithelial to mesenchymal transition in oesophageal adenocarcinoma, an immunohistochemical study.

Prins MJ, Ruurda JP, Lolkema MP, Sitarz R, Ten Kate FJ, van Hillegersberg R.

J Clin Pathol. 2015 Jul;68(7):529-35. doi: 10.1136/jclinpath-2015-202962. Epub 2015 Apr 8.

PMID:
25855799
17.

Mesenchymal phenotype after chemotherapy is associated with chemoresistance and poor clinical outcome in esophageal cancer.

Hara J, Miyata H, Yamasaki M, Sugimura K, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y.

Oncol Rep. 2014 Feb;31(2):589-96. doi: 10.3892/or.2013.2876. Epub 2013 Nov 28.

PMID:
24297447
18.

Role of PRL-3, Snail, Cytokeratin and Vimentin expression in epithelial mesenchymal transition in breast carcinoma.

Patel NA, Patel PS, Vora HH.

Breast Dis. 2015;35(2):113-27. doi: 10.3233/BD-140395.

PMID:
25547164
19.

[Comparison of epithelial-mesenchymal transition-related markers between cancer tissue and tumor emboli].

He N, Wu GF, Zhao HY, Han HX.

Zhonghua Bing Li Xue Za Zhi. 2011 Nov;40(11):758-61. Chinese.

PMID:
22336160
20.

FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.

Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C.

World J Gastroenterol. 2015 Jan 7;21(1):196-213. doi: 10.3748/wjg.v21.i1.196.

Supplemental Content

Support Center